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Abstract
Background: The purpose of gene set enrichment analysis (GSEA) is to find general trends in the huge lists of
genes or proteins generated by many functional genomics techniques and bioinformatics analyses.
Results: Here we present SetRank, an advanced GSEA algorithm which is able to eliminate many false positive hits.
The key principle of the algorithm is that it discards gene sets that have initially been flagged as significant, if their
significance is only due to the overlap with another gene set. The algorithm is explained in detail and its
performance is compared to that of other methods using objective benchmarking criteria. Furthermore, we explore
how sample source bias can affect the results of a GSEA analysis.
Conclusions: The benchmarking results show that SetRank is a highly specific tool for GSEA. Furthermore, we show
that the reliability of results can be improved by taking sample source bias into account. SetRank is available as an
R package and through an online web interface.
Keywords: GSEA, Gene set enrichment analysis, Pathway analysis, Sample source bias, Functional genomics,
Algorithm, R package, Web interface
Background
A common feature of many current functional genomics
technologies, as well as many different types of bioinfor-
matics analyses, is that they output very large lists of
genes, typically in the order of hundreds or thousands.
Evidently, interpreting these lists by assessing each gene
individually is not practical. Therefore, Gene Set Enrich-
ment Analysis (GSEA) has become the first step in inter-
preting these long lists of genes. The principle of GSEA
is to search for sets of genes that are significantly over-
represented in a given list of genes, compared to a back-
ground set of genes. These sets of genes consist typically,
but not always, of genes that function together in a
known biological pathway. In practice, these gene sets
are compiled from gene and pathway annotation data-
bases such as GO [1], KEGG [2], Reactome [3], Wiki-
pathways [4], BioCyc [5] or others.
The most naive approach to GSEA is to use a one-
sided Fisher’s exact test, also known as hypergeometric
test, to determine the significance of over-representation
of a gene set in the input list. The drawback of this
method is that it requires a clear-cut boundary between
included and excluded genes. This distinction may be
clear in the case of qualitative experiments such as
certain types of proteomics analyses or computational
hard clustering analyses. In contrast, other types of
analyses, such as most transcriptomics experiments,
return a list of p-values associated with each gene. These
p-values express the significance that a gene is differen-
tially expressed between different conditions. Defining a
boundary between differentially expressed genes (DEGs)
and non-DEGs then relies on applying an arbitrary p-value
cutoff. Pan et al. [6] have shown that the choice of this
cutoff dramatically influences the outcome of a GSEA. As
a result, there has been a move away from using hypergeo-
metric methods in favor of other approaches. Tarca et al.
[7] have reviewed and benchmarked several of these
methods. In their paper, the authors make the distinction
between Functional Class Scoring (FCS) methods that cal-
culate a score based on a statistical value, such as p-value
or rank, for all genes that belong to a given gene set and
Single-Sample (SS) methods where for every gene set, a
score per sample is calculated. Despite these developments,
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the hypergeometric method is still widely used, mainly
because of its simplicity and because it can be applied to
problems other than GSEA. Eden et al. [8] have suggested
a method that, rather than applying a global cutoff,
determines the optimal cutoff for each gene set. This
method was originally used to assess the significance of
sequence motifs in promoter sequences [8] but can readily
be applied to GSEA as well [9].
As is clear from the previous paragraph, the problem of
calculating the significance of a single gene set is well-
studied and different adequate solutions exist. However,
some other issues still remain unresolved. Arguably, the
most important of these issues is that in a typical gene an-
notation database, many gene sets overlap as a result of
genes playing a role in different pathways and processes.
Table 1 shows the average fraction of intersecting gene set
pairs in several commonly used pathway databases. This
table shows that this phenomenon is not only limited to
the GO annotation database but occurs in virtually all da-
tabases. This seemingly obvious and trivial fact has serious
repercussions for GSEA as it confuses the results. Indeed,
when several gene sets share a significant proportion of
their genes, deciding which gene set from a list of related
sets is the most relevant, becomes problematic when no
additional information is provided. This problem becomes
even more complicated when subset relations exist be-
tween the different gene sets in annotation databases.
Such relations are most notable with the Gene Ontology
[1], but also exist in other databases such as Reactome [3]
or KEGG [2]. Several authors have tried to address this
problem. PADOG [10] is an FCS-type method that down-
weights genes that are part of multiple gene sets. Although
the authors show that this approach improves results,
from a biological perspective one can argue against penal-
izing genes simply because they are involved in multiple
pathways, since those genes are likely to be key regulators.
Other methods have used the explicit graph structure of
the Gene Ontology to integrate results. BiNGO [11]
simply visualises the GSEA results on top of the Gene
Ontology graph. TopGO [12] implements two different
ways of using GO structure to improve results. The first
method removes genes that belong to a significant set
from all its supersets. When a superset is still found to be
significant, all of its genes are then also removed from its
own supersets and so on. The other method simply down-
weights genes belonging to significant subsets. Although
these solutions are simple and elegant, they only address
subset relations and do not take gene sets into account
that only intersect with one another. Jiang and Gentleman
(2007) address this problem by calculating for each pair of
intersecting gene sets three separate p-values: two for the
respective set differences and one for the intersection.
Another problem is that a typical GSEA run returns tens
to even hundreds of significant gene sets, depending on the
combination of algorithm and databases used. Clearly,
when the goal of GSEA is to facilitate the interpretation of
long lists of genes, merely converting these into long lists of
gene sets helps little to nothing in solving the original prob-
lem. An additional difficulty is that correcting for testing
multiple gene sets is not feasible using traditional correc-
tion methods due to the many overlaps between these sets
which violate the independence assumption of these
methods. This problem becomes even more complex when
one wants to query multiple gene set resources, such as the
three different GO domains, biological process, molecular
function and cellular component, together with, e.g.
Wikipathways and Reactome. One could evaluate a dataset
against each of these resources separately but that would
only result in disjoint result sets, making the final interpret-
ation even harder. Moreover, combining different gene set
resources into a single database and then querying the
latter, will result in a very long list of significant gene sets
with many overlaps between them as some pathways will
be defined in multiple resources. The same principle is also
used by Nam et al. [13].
Some methods have been developed to address simul-
taneously the overlap and the multiple testing problem
using generative models [14, 15]. GenGO [14] tries to
Table 1 Overview of the extent of overlapping gene sets in some commonly used gene set databases
DB # sets median size % overlap Min. p25 Median p75 Max.
BIOCYC 596 3 3.4% 1.45% 11.61% 20.00% 38.46% 100.00%
GOBP 14524 6 18.2% 0.01% 0.31% 0.76% 1.75% 100.00%
GOCC 1751 7 15.8% 0.01% 0.16% 0.49% 1.45% 100.00%
GOMF 4388 3 6.1% 0.01% 0.17% 0.50% 1.53% 100.00%
KEGG 956 29 13.1% 0.07% 1.61% 4.12% 8.98% 100.00%
Pathway Interaction Database 186 32.5 50.5% 0.52% 1.75% 3.45% 6.38% 63.64%
REACTOME 1784 19 11.8% 0.04% 1.00% 2.44% 6.29% 100.00%
WikiPathways 239 32 26.5% 0.24% 1.31% 2.61% 5.34% 100.00%
Only gene sets with three or more genes were considered. The % overlap column indicates the percentage of gene set pairs sharing at least one gene. The
column Min., p25, Median, p75 and Max. list the minimum, 25th percentile, median, 75th percentile and maximum Jaccard values for all pairs of intersecting
gene sets
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identify the smallest combination of gene sets that pro-
vides the best explanation for the activation of genes in
the input list. Although the principle is elegant, this
method still requires a cutoff to divide the input gene list
into those activated and non-activated genes. Moreover, it
also requires an additional arbitrary penalty parameter a,
which has no empirical meaning. Model-based Gene Set
Analysis (MGSA [15]) tries to mitigate these limitations
by assuming that the real activation state of a gene is
hidden and has to be estimated from the observed data.
Although it improves robustness, this change still does
not eliminate the cutoff requirement.
Another question is how to determine the background set
of genes against which to test for over-representation. Most
of the methods discussed above simply use all genes present
in the input dataset or even all genes annotated on the gen-
ome as the background. Doing so, however, introduces a
particular type of bias into the results, which we refer to as
sample source bias. Sample source bias occurs when the
gene sets returned by GSEA describe the sample rather than
the condition being tested. Carefully selecting the back-
ground set can eliminate this bias. Although it is arguably
an important consideration, surprisingly very few authors
have addressed the issue of background selection. To the
best of our knowledge, only Maere et al. [11] and Falcon
and Gentleman [16] mention this problem.
In this paper, we present SetRank, a novel GSEA
algorithm which addresses the overlap and multiple test-
ing problems and allows to query different annotation
databases simultaneously. It builds on the idea of Jiang
and Gentleman [17] to detect and remove false positive
hits based on their overlap with other gene sets. We ex-
tend this approach by integrating the remaining results
in a gene set network. The topology of this network is
used to prioritise the final set of results.
Using the same validation method and dataset used by
Tarca et al. [7], we show that these different steps dramatic-
ally increase the specificity of gene set detection compared
to other methods. Apart from this algorithm, we also show
how sample source bias can be overcome by defining a
correct background set. This step is very straightforward
for RNA-seq and shotgun MS-proteomics datasets. For
DNA microarray data, it is a little more complicated as this
technology does not readily allow to detect presence or
absence of a given transcript. Here, we also propose a sim-
ple method to define a background set for DNA microarray
datasets. We finally demonstrate how defining a proper
background set improves the reliability of results.
Results
Description of the algorithm
The SetRank algorithm takes as input a gene set collection
and a list of genes. The gene set collection can be com-
piled from different pathway and annotation databases,
allowing to query all these resources simultaneously. The
list of genes is typically the result of an omics experiment,
such as an RNA-seq assay. In most cases, this list will be
ranked according to a p-value expressing the significance
of difference in expression between two conditions. It is
also possible to supply an unranked list, e.g. the result of a
qualitative proteomics experiment or a genome-wide mu-
tation screen.
In a first step, a primary p-value is calculated for every
gene set in the collection. Depending on whether the input
gene list is ranked according to significance or unranked, a
different method is used for this calculation. For ranked
gene lists, we use a simplified version of the method
described by Eden et al. [8, 9] (see subsection Algorithm
details of the Methods section). This method does not
depend on an arbitrary cutoff to divide the input gene list
into significant and non-significant genes. We choose to
not implement the dynamic programming approach
proposed by Eden et al. [8] to correct for multiple testing
because of performance considerations. In contrast to Eden
et al., our algorithm needs to perform many re-calculations
of the p-value of a single gene set further on (see below).
After calculating the primary gene set p-values, gene sets
whose significance is only attributed to the overlap with
another gene set, are discarded. This principle is derived
from Jiang and Gentleman [17] and is illustrated in Fig. 1.
Although both sets shown would initially be considered as
significant, it is clear that the significance of gene set B is
solely due to its overlap with gene set A. The exact details
of this procedure are discussed in Algorithm Details.
This reduction of initially returned gene sets vastly facil-
itates the interperation of any GSEA analysis. However,
there are often still too many different gene sets left after
the initial removal step. Moreover, there is often still con-
siderable overlap between any two gene sets, or one set
might be a proper subset of another one. These underlying
relations make the interpretation of a simple list of gene
sets very difficult as the items on the list are not independ-
ent of one another. This problem becomes even more
apparent when combining different gene set databases.
A B
Fig. 1 Principle of eliminating false-positive gene set hits. Shown is
a Venn diagram of two hypothetical intersecting gene sets. The full
dots represent genes determined as significant by a genomics
experiment, empty dots represent non-significant genes
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To facilitate the interpretation of results, we represent
the output of the SetRank algorithm as a directed graph
which we refer to as a gene set network. In this graph,
nodes represent gene sets and edges represent intersec-
tions between them. As shown in Fig. 2, we can distin-
guish between three types of edges. The first and most
common one, is an intersection between two gene sets. In
this case, it is possible to determine which one of these
two sets is the most significant, based on the p-value
obtained after subtracting the intersection. The resulting
edge will then be directed from the less significant to the
more significant set. The second type of edge occurs
when, after subtracting the intersection from both sets,
neither one of them remains significant. This situation
arises when the vast majority of significant genes lies in
the intersection (see Fig. 2). The third type of edge are
cases where one set is a proper subset of another, that is,
all elements of the first are also part of the second gene
set. Figure 3 shows an example of a gene set network.
Although a gene set network is a very suitable way to
visualise the results of SetRank, researchers wishing to
understand their dataset can still be left with a very large
number of gene sets to evaluate. To help prioritise which
gene sets to investigate first, a score, called the SetRank
value, is calculated for each gene set in a gene set network.
This value reflects the prominence of a gene set in a gene
set network. It is based on the fact that edges representing
normal intersections are drawn from the least to the most
significant gene set (see before and Fig. 2). Thus, when a
node in a gene set network has a lot of incoming edges,
this means that this set is more relevant for a given dataset
than a node with a lot of outgoing edges.
The SetRank value is calculated using the PageRank
algorithm [18], which is a commonly used method in
network analysis. The SetRank value is determined by
counting the number and quality of incoming edges to a
node to determine the importance of that node. The
quality of an edge depends on the SetRank value of the
originating node. The SetRank value is thus a recursive
score and is determined iteratively. In addition, we also
calculate a p-value for each node which expresses the
signifcance of its SetRank value, given the number of
nodes and edges in the gene set network.
Implementation and availability
An implementation of the SetRank algorithm is available
as an R package at the CRAN repository. This package
provides all functionality to run a SetRank analysis on an
input dataset and returns a gene set network. Additionally,
it also provides routines to export the results to tabular
format and the gene set network as a GraphML file for
visualisation with Cytoscape [19]. Apart from visualising
the gene set network, the SetRank package also provides
functionality to visualise interactions between individual
genes inside a significant pathway. To this end, known in-
teractions between genes are first retrieved from the
STRING database [20]. The fold-change and p-value of
each gene in the original input expression data is then
visualised on top of the resulting network as node color,
ranging from cyan to blue for negative values over black
for zero to yellow and red for positive values, and node
font size, with bigger fonts for lower p-values, respectively.
Node size and edge thickness reflect betweenness, which
is a measure of network centrality and can help in asses-
sing the importance of a given node in the network. An
example of this visualisation is shown in Fig. 4.
Next to this R package, two stand-alone packages are
also made available. The first one, GeneSets, can be used
to create gene set collections for one or more user-
specified organisms. This package consists of a set of
scripts that will download data from various online re-
sources and creates for each organism an R package that
is ready for use with the SetRank package. The second
one, SetRank_interactomes, retrieves species-specific
interaction data from the STRING database [20] for use
with the gene network visualisation routines. The Gene-
Sets and SetRank_interactomes packages are available
from https://github.com/C3c6e6/GeneSets and https://
github.com/C3c6e6/SetRank_interactomes respectively.
In order to accommodate users that are not familiar with
the R programming language, an online interface of
SetRank has also been developed and made available at
http://setrank.vital-it.ch. This web-interface allows a user to
upload one or more tables of gene identifiers with
associated p-values. Currently the following organisms are
supported: Caenorhabditis elegans, Drosophila melanoga-
ster, Escherichia coli, Homo sapiens, Mus musculus, Rattus
Fig. 2 The different edge types in a gene set network (same key as Fig. 1). 1. Normal overlap. Both gene sets are significant but the significance
of gene set B is partly due to its overlap with gene set A as the latter has more significant genes. 2. Intersection only. This is the special case
where the significance of either gene set is purely due to the intersection between both. 3. Subset. Gene set B is a proper subset of gene set A
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Fig. 3 Example of a gene set network returned by SetRank. The node fill color reflects the corrected p-value, going from blue to red with
decreasing p-value (i.e. increasing significance; see inset, pp denotes the negative logarithm of the p-value). The node border color reflects the
SetRank p-value, using the same color coding as the node fill color. Edge thickness reflects the size of the intersection between two gene sets,
using the Jaccard similarity. The edge arrows point from the least significant gene set to the more significant one after subtracting the
intersection from both of them. A double-line edge indicates a case where the significance of both gene sets was only in the intersection
Fig. 4 Example of a visualisation of a significant pathway using the SetRank package. Shown are the interactions between genes in the “Acute
Myeloid Leukemia (AML)” gene set of the KEGG DISEASE database. The expression data from dataset GSE14924 CD4, which compared AML
patients to healthy subjects, is overlayed on top of the network. Node color reflects the log-fold change; the size of the node label reflects the
significance of difference in expression; the node label color reflects the gene rank when sorted by p-value – a rank of 1.0 means the lowest
p-value. The node width reflects the global betweenness, i.e. the betweenness of a node in the entire interactome; the node height the local
betweenness, i.e. the betweenness in the pathway; the node border color reflects the log-ratio between the local and global betweenness
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norvegicus and Saccharomyces cerevisiae. Note that this list
may be extended depending on demand from the users.
The data is then analysed on the Vital-IT high performance
computing infrastructure and the user is notified when the
analysis is finished. The resulting gene set networks as well
as the gene interaction networks can be visualised within
the web browser. Figure 5 shows the visualisation of a gene
interaction network of a pathway detected by SetRank using
the web interface. All generated results are also available for
downloading and off-line analysis with Cytoscape or an-
other graph analysis tool.
Benchmarking
To assess the performance of the SetRank algorithm we
use the benchmarking method proposed by Tarca et al.
(2013). These authors have compiled a corpus of 42
microarray datasets that compare patients with a given
disease phenotype against healthy individuals. For each of
the phenotypes, a matching gene set from the KEGG DIS-
EASE database, referred to as the target set, was identified.
Using this information, the performance of a GSEA
method can be assessed by how well it identifies the target
gene sets in all of the input datasets. Tarca et al. used three
different metrics to evaluate performance. The first of
these is sensitivity. Tarca et al. used a surrogate score for
sensitivity, defined as the median p-value of the target set
in each dataset.
For simplicity, we will in the remainder of this manu-
script refer to this score as sensitivity. Second, prioritisation
is defined as the median rank of the target gene set divided
by the total number of gene sets tested. Third, specificity, is
expressed as the false positive rate at a significance level of
1%. The false positive rate is determined by counting the
number of gene sets determined as significant after ran-
domly permutating the genes in all datasets.
We conducted two different SetRank runs on each data-
set. In the first run, probesets for which no transcript was
detected were filtered out (see below and Methods). In the
second run, all probesets were included. These runs are
further referred to as the filtered and no-filter runs re-
spectively. The results for each run are shown in Table 2,
together with the benchmarks of other methods, taken
from Tarca et al.
A problem in calculating these metrics is that SetRank
does not rank every gene set from the initial database in
the output results as the algorithm discards gene sets at
two different checkpoints in the process. As explained in
the Methods section, all gene sets with a primary p-value
above 0.05 are immediately discarded. In addition, gene
sets considered as false positives due to their overlap with
other sets, are also discarded. In both runs, the target gene
sets were ranked in 10 out of 42 datasets. For the sensitiv-
ity calculation, we can assign a p-value of 1 whenever the
target set was not found. As result, the median p-value for
all runs is 1, simply because the target gene set was not
ranked in the majority of datasets. If we, however, define
the sensitivity as the median of the initial p-values of the
target gene sets, we obtain a value of 0.0997, which is
largely on par with the other methods.
For the prioritisation, we only calculate the median for
those datasets where the target set was ranked. The results
show that for the cases where the target set was ranked, the
obtained prioritisation score, 0.75% is about one order of
magnitude better than the second-best performing method,
Fig. 5 Screenshot of the SetRank web interface
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PADOG, with 9.70%. The false-positive rate of SetRank is
0.09%, which is substantially lower than that of CAMERA,
0.50%. Together, these data show that SetRank has a
dramatically improved specificity, both in terms of false-
positive rate and of prioritisation, compared to other
methods, at the expense of a lower sensitivity.
Influence of sample source bias on the results
As mentioned in the introduction, a poorly chosen back-
ground set can introduce sample source bias into the
dataset. Sample source bias occurs when the gene sets
returned by a GSEA algorithm describe the sample rather
than the condition. Suppose for instance, that one analyses
data from an experiment that compares brain tumour
samples against healthy brain samples. Besides general cel-
lular processes such as cell cycle or vesicle transport, a
typical gene set database also contains gene sets that de-
scribe processes that are tissue or organ-specific, such as
synaptic transmission or brain development in the case of
brain. Only a few of these processes, if any, will be truly af-
fected by the condition being tested, in this case tumour
growth. As explained before, truly affected gene sets are
enriched with significant genes, whereas other gene sets
contain values drawn uniformly from the entire p-value
range. The issue of sample source bias arises when tissue-
specific gene sets are tested for significance against a back-
ground set of genes consisting of the entire genome. Fig-
ure 6 illustrates this problem. Indeed, a brain-specific gene
set that is not truly affected will still be found to be signifi-
cant as one compares a list of genes expressed in the brain
against those expressed in all other parts of the body. As a
result, the returned gene sets will describe both the condi-
tion being tested as well as the brain itself. If, on the other
hand, one uses a background set containing only genes
that are expressed in the brain, the returned gene sets will
be specific only to the condition tested.
In the ideal case, the perfect background set consists of
all genes that can be expressed in the tissue type under
study. Several resources have already been developed to
characterise the complete expression profiles of several
human [21] or animal [22] tissues under normal condi-
tions. Although these are useful resources, they fall short
when one wants to compare abnormal tissue, such as
tumor samples, or very specific cell types such as immune
cell populations. The next best solution to construct a
background set is to take all genes that are positively iden-
tified at least once in any of the sample groups in the data-
set being analyzed. When using a technology that detects
absolute transcript or peptide levels, such as RNA-seq or
shotgun proteomics, a background set is easily compiled.
In the case of DNA microarray datasets, the solution is
less straightforward as there is no definite cutoff value for
the expression intensity of a probe set to determine if a
transcript is detected or not. One can, however, expect
that the intensities of a probe set for which a transcript is
not present in any of the samples in the dataset, will have
Table 2 Benchmarking results for SetRank compared to other
methods
Method Sensitivity Prioritization Specificity
PLAGE [28] 0.0022 25.00% 1.10%
GLOBALTEST [29] 0.0001 27.90% 2.00%
PADOG [7] 0.096 9.70% 2.50%
ORA 0.0732 18.30% 2.50%
SAFE [30] 0.1065 18.80% 1.30%
SIGPATHWAY Q2 [31] 0.0565 38.00% 0.90%
GSA [32] 0.142 21.00% 1.30%
SSGSEA [33] 0.0808 40.30% 1.00%
ZSCORE [34] 0.095 39.80% 1.00%
GSEA [35] 0.1801 33.10% 2.30%
GSVA [36] 0.1986 51.50% 1.10%
CAMERA [37] 0.3126 43.00% 0.50%
MRGSE [38] 0.01 18.80% 4.90%
GSEAP 0.0644 36.20% 15.80%
GAGE [39] 0.0024 35.90% 37.90%
SIGPATHWAY. Q1 0.1165 49.70% 17.20%
SetRank filtered 1.0 0.75% (10) 0.09%
no filter 1.0 2.05% (10) –
Scores for other methods are taken from Tarca et al. [7]. The best score in each
category is highlighted in italic. Note that the prioritisation score for SetRank is
based only on the datasets where the target set could be ranked. The numbers
in brackets indicates the number of datasets where this was the case
Fig. 6 The principle of sample source bias. The black bar represents the group of genes that are not expressed in any sample analysed. The
gradient-filled bar represents the set of genes expressed in at least one sample, ordered by significance of differential expression between the
different conditions tested. The inset box marked “sample-specific gene set” denotes a gene set that contains genes that are evenly distributed
among all significance values of the expressed genes; the one marked “treatment-specific” gene set is highly enriched in significant differentially
expressed genes. Note that the box size does not reflect the gene set size but merely the range of significance values of its genes
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both low mean and variance values. Using this principle,
we devised a simple scheme to remove undetected tran-
scripts from the dataset (see Methods).
The influence of background selection is not obvious
when only evaluating gene sets from the KEGG DIS-
EASE database. Indeed, although there is a difference
between the median prioritisation scores (see Table 2),
there is no overall significant difference between both
the p-values (Mann–Whitney test, p = 0.15) and the pri-
oritisation scores (p = 0.55) of the filtered and unfiltered
runs. This lack of effect is probably due to the fact that
the KEGG DISEASE gene sets only describe specific dis-
eases and not tissue-specific processes.
To demonstrate the effect of sample source bias properly,
we re-analysed the benchmarking datasets with a more
general purpose gene set database, the Biological Process
terms of the Gene Ontology (GOBP). For this analysis, we
only considered those datasets that are derived from brain
tissue, as this is the most abundant tissue type in the entire
corpus of benchmarking datasets (9 out of 42). Each dataset
was analysed with SetRank using three different back-
ground sets. The first background set consisted of all genes
represented on the microarray used, the second had all
genes considered to be not expressed removed, and the
third had an equal amount of randomly selected genes re-
moved. The Setrank runs conducted with these background
sets are respectively referred to as the ‘no filter’, ‘filter’ and
‘random filter’ runs.
The aim of this analysis is to investigate to which extent
the choice of background set influences the occurrence of
brain-related terms in the output of SetRank. We hypothe-
sise that using a tissue-specific background set will reduce
the occurrence of brain-related gene sets in the output of
SetRank. To test this hypothesis, we compared the signifi-
cance of brain-specific GO terms between these three runs.
Here, a brain-specific term is defined as any GO term that
inherits from the ancestral terms “nervous system develop-
ment” (GO:0007399), “neurological system process”
(GO:0050877), or “synaptic transmission” (GO:0007268).
Note that there are other terms, such as “regulation of
neuron apoptotic process” (GO:0043523) that are clearly
related to brain function but inherit from more general
process terms such as “regulation of apoptotic process”
(GO:0042981) and are scattered all over the GO graph.
These terms are not considered here as they can not be
readily included using objective criteria.
The results of these three runs for one dataset
(GSE19728), which compares brain tumour samples to
healthy brain tissue, are shown in Table 3. Both the ‘no
filter’ and ‘random filter’ runs have four brain-specific
terms among the ten top ranked gene sets, whereas the
‘filter’ run only has one. The results for this single data-
set already indicate that the choice of background set
plays a role in reducing sample source bias as the four
brain-specific terms in the ‘no filter’ and ‘random filter’
terms most likely only describe the sample, i.e. the brain,
rather than the condition being tested.
To investigate if this trend is persistent across all nine
brain datasets, we calculated for each SetRank analysis
the negative logarithm of the product of the corrected p-
values of all brain-specific GO terms detected as a score
for the total significance of these terms. These scores are
shown in Fig. 7. Comparing these scores with a one-
tailed Wilcoxon signed rank test, we see that scores of
the ‘filter’ runs are significantly lower than those of the
‘no filter’ runs (p = 0.02), whereas there is no significant
difference between the ‘no filter’ and ‘random filter’ runs
(p = 0.10). These results demonstrate that removing
non-expressed genes from the background set helps to
eliminate sample-specific gene sets from the analysis re-
sults and that this elimination is not due to a loss in stat-
istical power caused by a smaller background set.
Discussion
Assessing the performance of a GSEA method is not
straightforward as it is hard to know beforehand which
gene sets should be considered as true positives. Many au-
thors have used simulated data to validate their method
[14, 15, 23]. The validity of this approach is however debat-
able, as one can tweak the simulation model to give optimal
results. The strategy proposed by Tarca et al. [7] which we
used here, provides an objective benchmark to evaluate
different methods. It should be stressed though that this
approach is by no means perfect. Indeed, the KEGG disease
database consists of collections of genes implicated in
specific diseases, including many genomic biomarkers. As
the benchmarking approach suggested by Tarca et al. is
based on analysing transcriptomics data, one can only
detect the target gene set when the expression levels of the
included biomarkers are sufficiently affected, which is an
unlikely assumption. Therefore, there is no guarantee that
the designated target gene set in the benchmarking corpus
for a specific disease is actually the most relevant one.
Nevertheless, this approach allows at least to assess the
relative performance between different methods.
As mentioned in the description of the algorithm, we
have chosen not to implement the multiple testing cor-
rection method used by Eden et al. [8] when calculating
the initial p-value of a gene set. Instead, our method de-
tects false-positive hits by discarding gene sets based on
their overlap with other sets. The very low false-positive
rate observed in the benchmarking results clearly shows
that this approach is very effective. Thus, our approach
of false-positive detection can be seen as a data-driven
form of multiple-testing correction.
As can be seen from the benchmarking statistics, the
sensitivity, as expressed in median p-value of the target
sets, of our method is rather poor at first sight, with a
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Table 3 The effect of sample source bias on dataset GSE19728
No filter Filter Random filter
1 regulation of synaptic transmission
(GO:0050804)
neurotransmitter transport
(GO:0006836)
regulation of synaptic plasticity
(GO:0048167)
2 neuron-neuron synaptic transmission
(GO:0007270)
regulation of exocytosis
(GO:0017157)
pallium development
(GO:0021543)
3 regulation of Rho protein signal transduction
(GO:0035023)
regulation of transporter activity
(GO:0032409)
telencephalon development
(GO:0021537)
4 establishment of vesicle localization
(GO:0051650)
membrane depolarization
(GO:0051899)
positive regulation of cell development
(GO:0010720)
5 synaptic vesicle transport
(GO:0048489)
regulation of ion transmembrane transporter
activity (GO:0032412)
membrane depolarization
(GO:0051899)
6 positive regulation of cell development
(GO:0010720)
positive regulation of cell development
(GO:0010720)
establishment of organelle localization
(GO:0051656)
7 regulation of postsynaptic membrane potential
(GO:0060078)
establishment of vesicle localization
(GO:0051650)
regulation of Rho GTPase activity
(GO:0032319)
8 regulation of Rho GTPase activity
(GO:0032319)
positive regulation of cell projection organization
(GO:0031346)
synapse organization
(GO:0050808)
9 regulation of neuron apoptotic process
(GO:0043523)
peptidyl-serine phosphorylation
(GO:0018105)
vesicle localization
(GO:0051648)
10 membrane depolarization
(GO:0051899)
regulation of peptide secretion
(GO:0002791)
establishment of vesicle localization
(GO:0051650)
Brain-specific GO terms are marked in italic.
Fig. 7 The influence of background selection on brain-tissue derived datasets. The height of the bars indicates the score which represents the
total significance of all brain-related gene sets. See the main text for details
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value of 1. As mentioned above, this score is mainly an
artifact of our algorithm not assigning a p-value to all in-
put gene sets. If we look at the median of the initial p-
values of the target sets, we obtain a value of 0.0997,
which is still better than 6 out of 16 of the methods
listed in Table 2.
In practice, the limited sensitivity of SetRank is un-
likely to be a problem as the number of gene sets ini-
tially returned by GSEA typically runs in the hundreds,
especially when querying multiple databases. Indeed,
during our analysis of the brain-specific datasets using
only the GOBP database, we found on average 333 ini-
tially significant gene sets, with a standard deviation of
34.7. Moreover, the gene sets in the KEGG DISEASE
database are a lot smaller (average size 4.68) compared
to other databases such as GOBP (average size 80.0)
which further diminishes the issue of limited sensitivity
as larger gene sets are more readily detected due to in-
creased statistical power. Note, however, that SetRank is
still capable of detecting small gene sets. Indeed, in our
analysis of the brain-specific datasets with the’filter’
runs, we detected on average 131 significant gene sets
with 10 or less genes (standard deviation 10.5) and 76
gene sets with 3 or less genes (standard deviation 7.7).
Finally, it should be noted that for 12 out of the 16
methods benchmarked by Tarca et al., the median p-
value for the target gene set is higher than 0.05. This ob-
servation means that, for the majority of datasets in the
benchmarking corpus, these methods would not detect
the target sets either when applying a p-value cutoff of
0.05 on the returned gene sets. Thus, in practice, the
sensitivity of our method is on par with the bulk of the
other GSEA methods available.
Contrary to the sensitivity, the statistics for prioritisa-
tion and false-positive rate show that our method signifi-
cantly outperforms all other methods available. A
prioritisation score of 0.75% on KEGG DISEASE, a gene
set database with 522 gene sets, means that our method
ranks the target gene set consistently within the top 4
ranked gene sets, whenever it is detected. As this result
is only based on 10 out of 42 benchmarking datasets, a
direct comparison of this score with the other methods
is unfair. Nevertheless, taken together with the very
good specificity score, the low prioritisation score does
demonstrate that, whenever SetRank does assign a low
rank to a gene set, it is very likely to be relevant. One
reason for this excellent performance is that we do not
order the final results on corrected gene set p-value
alone but also on the topology of the gene set network.
The advantage of this approach is illustrated in Fig. 3
which visualizes the results on dataset GSE14924_CD4,
which compares the transcriptomes of patients with
Acute Myeloid Leukemia to those of healthy subjects.
Although the target gene set “Acute Myeloid Leukemia”
does not have the lowest p-value, as can be seen from
the node fill color, it has the highest SetRank value and
is consequently ranked first in the final result list.
The obtained specificity value, 0.09%, is again much
lower compared to all other methods and is probably
due to the FDR correction applied by our algorithm on
the different connected components in the gene set net-
work. Other GSEA methods do not perform FDR cor-
rection, as the latter assumes statistical independence of
the entities tested, which is clearly not the case for inter-
secting gene sets. However, this assumption does hold in
the case of separate network components as they, by
definition, do not share any genes.
The SetRank algorithm itself is controlled by two
parameters. The first one is the p-value cutoff applied to
discard non-significant gene sets in the first filter step as
well as during the elimination of false positives. During
our benchmarking analysis, we have set this value to 0.05.
Although setting this parameter is an arbitrary decision,
its value has little effect on the overall performance of
SetRank. Indeed, applying a stricter cutoff, only affects the
sensitivity performance of our method, as fewer gene sets
will be finally ranked. As discussed before, the prioritisa-
tion score mainly depends on the topology of the gene set
network. Although a stricter cutoff results in fewer nodes,
the edge directions, which are used to determine the
SetRank score of a node, of the remainig nodes are not af-
fected. The second parameter, the FDR cutoff, has no ef-
fect on neither the sensitivity nor the prioritisation. The
specificity in our benchmarking is defined here as the
number of false positive results at a significance level of
1%. As a result, the FDR cutoff also has no influence on
this metric. Apart from these, the process that builds the
gene set collection has one additional parameter, the
maximum size of gene sets to include. This parameter was
added to avoid the inclusion of vague, general gene sets,
such as “metabolic process” into the results, at the
expense of more precise, smaller sets.
The analysis of the influence of sample source bias illus-
trates the importance of defining an appropriate background
set. To the best of our knowledge, this paper is the first to
include a thorough analysis of this phenomenon. Our ana-
lysis shows that removing non-expressed genes from the
background set significantly reduces the occurrence of
tissue-specific gene sets in the output of GSEA. Note that
we do not want to exclude these gene sets a priori, but to
ensure that, when they turn up as significant, their signifi-
cance is actually due to the effect being measured. Thus, the
few tissue-specific gene sets that remain after applying a cor-
rected background set can then be interpreted as processes
that are genuinely affected by the condition studied. The
benchmarking results for the filter run show no significant
loss of statistical power resulting from smaller background
sets, as the target set is detected in just as many cases.
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Conclusion
The combination of excellent prioritisation and specificity
scores, ensures that SetRank returns either reliable results
or no results at all, making it a highly reliable method for
GSEA and ideally suited for querying multiple gene set
databases simultaneously. This reliability can be further
improved by eliminating sample source bias.
Methods
Algorithm details
Calculating primary gene set p-values
Depending on whether the input gene list is ranked or not,
a different method is used to calculate the primary p-values
of all gene sets in the input gene set collection. For ranked
gene lists, we use a simplified version of the method de-
scribed by Eden et al. [8, 9] This method takes as input the
list L of all genes present in the dataset, ranked by increas-
ing p-value and a gene set S ⊂ L, also ranked in the same
way as L. Let l and s denote the sizes of L and S respect-
ively. Further, let, for a gene gi Є S, i Є {1, …,s} denote the
rank of gt in S and lt the number of genes in L that rank
above or equal to – i.e. have a p-value less or equal to – gt.
The p-value of gene set S is then given by
p ¼ minPF i s−ili−i li− li þ s−ið Þ
 
where PF is the p-value obtained by applying a one-
tailed Fisher exact test on the 2 × 2 contingency matrix.
The lowest p-value obtained for all values of i is then
used as the final p-value.
The original method by Eden et al. [8] uses a sophisti-
cated approach to correct for multiple testing by apply-
ing a dynamic programming algorithm. For reasons of
computational efficiency, we do not correct for multiple
testing at this stage.
For methods that do not provide a means of ranking genes
according to significance scores, such as clustering analysis,
a Fisher exact test can be used to calculate the p-value of a
gene set. In this case, the input consists of the same list L
and gene set S as used above as well as an additional cluster
of genes C ⊂ L. Let l, s, and c denote the sizes of L, S, and C
respectively and let n = |C ∩ S|. In this case, the p-value that
expresses how significantly S is over-represented in C com-
pared to all of L, is given by
p ¼ PF n s−nc−n l− cþ s−nð Þ
 
After calculating the primary p-values, we discard all
gene sets with a p-value above a user-defined threshold.
To avoid false negatives – i.e. gene sets that are wrong-
fully discarded – we recommend to only apply a loose
cutoff in this phase, typically in the range of 0.01 – 0.05.
Eliminating false positives
The procedure to eliminate false positive gene sets in-
volves testing all pairwise combinations of the initially
retained gene sets. As a result, the computation time
scales quadratically with the number of retained gene
sets. To reduce calculation times, we first compute the
list of set pairs whose intersection is significantly larger
than expected by chance so as to only compare pairs of
gene sets that are biologically related. This filtering step
is accomplished by calculating for each pair of sets M
and N with sizes m and n, both subsets of a larger set L
with size l, the probability p that they share at least i ele-
ments by chance, as given by:
p ¼ PF i n−im l− mþ n−ið Þ
 
Only pairs with a p-value below a certain cutoff are
retained. Again, we only use a permissive cutoff value here,
typically 0.01, without any correction for multiple testing.
In the next step, we iterate over the obtained list of
significant set pairs to detect false positive gene sets. For
every pair of sets A and B, we recalculate for each set a new
p-value, p′, this time using only the set differences A′ =A\B
and B′ =B\A. If the value p′ of gene set A is higher than
the previously used cutoff and the p′ of B stays below this
cutoff, then this means that the significance of A was purely
due to its overlap with B (see Fig. 1). Gene set A is not im-
mediately discarded but the fact that it was invalidated by
gene set B is recorded. When A is a proper subset of B, only
the p-value of B will be re-evaluated.
After evaluating all gene set pairs in this manner, the
obtained information is used to construct a directed
graph where every node represents a gene set and edges
denote the previously determined invalidating relations
with the edges pointing to the invalidated nodes. The
purpose of this graph is to determine which gene sets
can be discarded as false positives. In the case of A→ B,
where A has no incoming edges and B none outgoing, B
will be discarded. In the more complicated case of A→
B→C →, where A has no incoming edges, only B will
discarded and C will be retained. This process is re-
peated until no more gene sets can be discarded. Note
that in the special case of A↔B neither set is discarded
as in this situation the majority of significant genes lies
in the intersection of both sets. Such cases are flagged
and indicated in the program output (see next section).
Gene Set network and prioritisation of gene sets
The results of the algorithm are stored in a gene set net-
work which can be visualised and analysed using network
analysis software tools such as Cytoscape [19]. Note that
this network is different from the graph created in the pre-
vious section which only contained invalidating relations.
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In the gene set network, all remaining gene sets are repre-
sented as nodes. Edges are drawn between any two nodes
of intersecting gene sets. We distinguish between three
different types of edges: subsets, intersections, and over-
laps (see Fig. 2). A subset edge is created when one gene
set is a proper subset of the other and is directed from the
subset to the superset. Intersection edges represent the
special cases A↔B from the previous section where the
genes that make both gene sets significant are only located
in the intersection. This type of edge has no direction.
Overlap edges denote all other cases of intersecting gene
sets. The direction of an overlap edge is towards the node
with the strongest, i.e. lowest, associated p′ value as dis-
cussed in the previous section.
To prioritise the collection of remaining gene sets, a
few additional values are calculated for each node. The
first two are the SetRank value and the associated p-
value. The SetRank value is determined by calculating
the PageRank value for each node, considering only the
overlap edges in the gene set network and using a damp-
ing factor of 0.85. Next, the PageRank values from 100
randomly generated networks with the same node and
edge count as the original network, are determined.
These values are then fit to a normal distribution to de-
termine the SetRank p-values for all nodes in the ori-
ginal gene set network, which are subsequently adjusted
for multiple testing using the Holm [24] method.
The corrected p-value of a gene set A is determined by
calculating the value p′ (see above) for each overlapping
gene set B, i.e. each neighbor node in the gene set network,
and taking the maximum of these values. Finally, a multiple
testing correction is applied on each of the weakly con-
nected components. First the p-value of a component is de-
termined by taking the minimum corrected p-value of all
its nodes. Second, the Holm method is used again to cor-
rect the component-level p-values for multiple testing.
The final results are first ordered by SetRank p-value,
then by adjusted p-value and finally by corrected p-value.
Benchmark analysis
All hybridisation CEL files for all 42 microarray datasets
used by Tarca et al. [7] were downloaded from the Gene
Expression Omnibus [25] website. All arrays were anno-
tated with either the HGU133A_Hs_ENTREZG or the
HGU133Plus2_Hs_ENTREZG chip definitions provided
by Dai et al. [26] and subsequently background-corrected
and normalised using the RMA method [27].
The KEGG disease gene set definitions were down-
loaded using the KEGGRest Bioconductor package.
Tarca et al. [7] have identified for each of these datasets
a target KEGG disease gene set.
SetRank was run on each dataset using the default set-
tings, meaning in ranked mode, with an individual set p-
value cutoff of 0.05, and an FDR cutoff of 0.05 using the
KEGG DISEASE gene sets. Two different runs of
SetRank were conducted on each dataset. In the first
run, referred to as the ‘filter’ run, probesets for which no
transcript was detected were filtered out (see below). In
the second run, referred to as the’no filter’ run, all probe
sets were included.
Detection calling on microarray datasets
To detect if a transcript for a given gene is detected in any
of the samples in a microarray dataset, we used a simple
filtering approach based on two cutoffs. The first cutoff is
the median of all relative median absolute deviations
(rMAD) for all probesets in a dataset. The rMAD is
defined as the median absolute deviation divided by the
mean. Note that this value is calculated on the non log-
transformed expression intensities. The second cutoff is
the 5th percentile of the mean expression value, calculated
on the log-transformed expression intensities, of all probe-
sets with an rMAD higher than the median. All probesets
with rMADs and means below both cutoffs are then con-
sidered to have not been detected in any of the samples.
Sample source bias analysis
For the sample source bias analysis, the 9 datasets from
the benchmarking corpus that are derived from brain tis-
sue were again analysed with SetRank, this time using
gene sets from the Biological Process domain of the Gene
Ontology [1], using the same settings as before. This time,
three runs were conducted on every dataset. Two of these
were a ‘filter’ and ‘no filter’ run, as described above. The
third run was a ‘random filter’ run where the same num-
ber of probesets was discarded as in the ‘filter run’, only
this time the probesets were randomly chosen.
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